References
- Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159–67
- Sibai BM, Taslimi MM, El-Nazer A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Am J Obstet Gynecol 1986;155:501–9
- Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000–6
- Martin JN Jr, Blake PG, Lowry SL, et al. Pregnancy complicated by preeclampsia-eclampsia with syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? Obstet Gynecol 1990;76:737–41
- Martin JN Jr, Blake PG, Perry KG Jr, et al. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991;164:1500–9
- Martin JN Jr, Magann EF, Blake PG, et al. Severe preeclampsia/eclampsia with HELLP syndrome in 454 pregnancies: comparative analysis using the 3-class system of classification. SMFM Abstract in Am J Obstet Gynecol 1993;168:266
- Magann EF, Bass D, Chauhan SP, et al. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1148–53
- Magann EF, Perry KG Jr, Meydrech EF, et al. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1154–8
- Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460–4
- Martin Jr JN, Thigpen BD, Rose CH, et al. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Amer J Obstet Gynecol 2003;189:830–4
- Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195:914–34
- Martin JN Jr, Owens MY, Keiser SD, et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hyperten Pregnancy 2012;31:79–90
- Martin JN Jr, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999;180:1373–84
- Darby M, Martin Jr JN, Mitchell SQ, Owens MY. Liver bleeding in patients with HELLP syndrome: pathogenesis and implications for preventive therapy. (Submitted for publication 2012)
- Diagnosis and Management of Preeclampsia and Eclampsia. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Number 33; January 2002
- Owens MY, Martin Jr JN, Wallace K, et al. Postpartum thrombotic microangiopathic syndrome (PTMS): a recognizable clinical scenario common to multiple uncommon diseases requiring plasma exchange to enable recovery. Transfus Apher Sci 2012 June 13 (epub ahead of print). PMID:22704633
- Abbade JF, Peracoli JC, Costa RAA, et al. Partial HELLP syndrome: maternal and perinatal outcome. Sao Paulo Med J 2002;120:180–4
- Liu C-M, Change S-D, Cheng P-J, Chao A-S. Comparisons of maternal and perinatal outcomes in Taiwanese women with complete and partial HELLP syndrome and women with severe preeclampsia without HELLP. J Obstet Gynaecol Res 2006;32:550–8
- Wang Y-Q, Wang J, Ye R-H, Zhao Y-Y. Investigation of diagnosis and treatment of hemolysis-elevated liver enzymes-low platelet counts (HELLP) syndrome: clinical analysis of 59 cases. Chin Med J 2010;123:1273–7
- Keiser SD, Owens MY, Parrish MR, et al. HELLP syndrome with and without eclampsia. Am J Perinatol 2011;28:187–94